| Target and Pathway |
Top |
| Target(s) |
Transforming growth factor beta 1 (TGFB1) |
Target Info
|
Inhibitor |
[1] |
|
KEGG Pathway
|
MAPK signaling pathway
|
|
Cytokine-cytokine receptor interaction
|
|
FoxO signaling pathway
|
|
Cell cycle
|
|
Endocytosis
|
|
TGF-beta signaling pathway
|
|
Osteoclast differentiation
|
|
Hippo signaling pathway
|
|
Intestinal immune network for IgA production
|
|
Non-alcoholic fatty liver disease (NAFLD)
|
|
Leishmaniasis
|
|
Chagas disease (American trypanosomiasis)
|
|
Malaria
|
|
Toxoplasmosis
|
|
Amoebiasis
|
|
Tuberculosis
|
|
Hepatitis B
|
|
HTLV-I infection
|
|
Pathways in cancer
|
|
Proteoglycans in cancer
|
|
Colorectal cancer
|
|
Renal cell carcinoma
|
|
Pancreatic cancer
|
|
Chronic myeloid leukemia
|
|
Inflammatory bowel disease (IBD)
|
|
Rheumatoid arthritis
|
|
Hypertrophic cardiomyopathy (HCM)
|
|
Dilated cardiomyopathy
|
|
NetPath Pathway
|
TCR Signaling Pathway
|
|
IL3 Signaling Pathway
|
|
TGF_beta_Receptor Signaling Pathway
|
|
Pathway Interaction Database
|
Glypican 1 network
|
|
IL27-mediated signaling events
|
|
Regulation of Telomerase
|
|
RXR and RAR heterodimerization with other nuclear receptor
|
|
AP-1 transcription factor network
|
|
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
|
|
ALK1 signaling events
|
|
Syndecan-1-mediated signaling events
|
|
Syndecan-2-mediated signaling events
|
|
TGF-beta receptor signaling
|
|
IL12 signaling mediated by STAT4
|
|
Reactome
|
Platelet degranulation
|
|
Molecules associated with elastic fibres
|
|
TGF-beta receptor signaling activates SMADs
|
|
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
|
|
Syndecan interactions
|
|
ECM proteoglycans
|
|
SMAD2/3 Phosphorylation Motif Mutants in Cancer
|
|
SMAD2/3 MH2 Domain Mutants in Cancer
|
|
TGFBR2 Kinase Domain Mutants in Cancer
|
|
TGFBR1 KD Mutants in Cancer
|
|
TGFBR1 LBD Mutants in Cancer
|
|
Transcriptional regulation of white adipocyte differentiation
|
|
WikiPathways
|
DNA Damage Response (only ATM dependent)
|
|
TCR Signaling Pathway
|
|
Senescence and Autophagy in Cancer
|
|
TGF Beta Signaling Pathway
|
|
ACE Inhibitor Pathway
|
|
Cytokines and Inflammatory Response
|
|
Endochondral Ossification
|
|
MAPK Signaling Pathway
|
|
TGF beta Signaling Pathway
|
|
NRF2 pathway
|
|
Nuclear Receptors Meta-Pathway
|
|
Vitamin D Receptor Pathway
|
|
Aryl Hydrocarbon Receptor Pathway
|
|
Extracellular vesicle-mediated signaling in recipient cells
|
|
IL-3 Signaling Pathway
|
|
Dopaminergic Neurogenesis
|
|
Endoderm Differentiation
|
|
Hematopoietic Stem Cell Differentiation
|
|
Differentiation Pathway
|
|
Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
|
|
Cardiac Hypertrophic Response
|
|
Syndecan interactions
|
|
Host Interactions with Influenza Factors
|
|
Transcriptional Regulation of White Adipocyte Differentiation
|
|
Signaling by TGF-beta Receptor Complex
|
|
Extracellular matrix organization
|
|
Elastic fibre formation
|
|
Primary Focal Segmental Glomerulosclerosis FSGS
|
|
Spinal Cord Injury
|
|
Cardiac Progenitor Differentiation
|
|
Integrated Pancreatic Cancer Pathway
|
|
Adipogenesis
|
|
Corticotropin-releasing hormone
|
|
Interleukin-11 Signaling Pathway
|
|
Allograft Rejection
|
|
Cell Cycle
|
|
TFs Regulate miRNAs related to cardiac hypertrophy
|
|
MicroRNAs in cardiomyocyte hypertrophy
|
